PA
Passage Bio
PASG·NASDAQPhiladelphia PAFounded 2017160 employees
Small CapbiotechPublicRare DiseaseNeurology
Platform: AAV Gene
Market Cap
$0.3B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (PASG)
Loading PASG stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PAS-2221 | PAS-2221 | Preclinical | 1 | GPRC5D | ASFTD | ||
| Lisonesiran | PAS-1848 | NDA/BLA | 2 | CD47 | GA |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)